| Bioactivity | CC15009 is a xanthine oxidoreductase (XOR) inhibitor, with an IC50 value of 0.237 nM. CC15009 can inhibit the oxidative subtype of XOR, thereby reducing the production of the byproduct ROS and exhibiting antioxidant activity. CC15009 has demonstrated a good dose-dependent uric acid-lowering effect in two different mouse models of hyperuricemia induced by XOR substrates[1]. |
| CAS | 2482713-67-5 |
| Formula | C20H21Cl2N5O2 |
| Molar Mass | 434.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Li X, et al. Identification of a novel xanthine oxidoreductase inhibitor for hyperuricemia treatment with high efficacy and safety profile. Biomed Pharmacother. 2024 Sep;178:117223. |
CC15009
CAS: 2482713-67-5 F: C20H21Cl2N5O2 W: 434.32
CC15009 is a xanthine oxidoreductase (XOR) inhibitor, with an IC50 value of 0.237 nM. CC15009 can inhibit the oxidative
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.